Diabetes
Conference Coverage
Small weight loss produces impressive drop in type 2 diabetes risk
“Treat obesity first,” said the authors of a study showing a loss of just 13% of body weight is associated with a significantly reduced risk of...
Feature
More U.S. states cap insulin cost, but activists will ‘fight harder’
Drugmakers and health insurers have not legally challenged state laws capping out-of-pocket insulin costs; still, such attempts to make insulin...
From the Journals
In Medicare, insulin costs more for patients who use pumps
The 50% price differential is an unintended consequence of the 21st Century Cures Act exacerbated by the overall rising cost of insulin.
News
FDA OKs new ‘artificial pancreas’ Medtronic 770G
The hybrid closed-loop MiniMed 770G automated insulin delivery system uses the same technology as the current 670G with added Bluetooth...
Feature
Black diabetics lose limbs at triple the rate of others. Here’s how health care leaders are starting to act.
The American Diabetes Association is creating an initiative to fight unnecessary amputations, which a ProPublica investigation found...
Conference Coverage
Gut bacteria linked to cardiovascular, other health conditions
“Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of...
Conference Coverage
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
Conference Coverage
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
Pearl of the Month
Vitamin D pearls
Risk factors for worse COVID-19 outcome are also risk factors for vitamin D deficiency.
From the Journals
FDA pulls amputation boxed warning off canagliflozin label
New safety information suggests the risk of amputation, while still increased with canagliflozin, is lower than previously described, particularly...
From the Journals
SGLT2 inhibitors with metformin look safe for bone
A meta-analysis of clinical trials finds no significant increase in fracture rate in type 2 diabetes patients taking SLGT-2 inhibitors plus...